Whitehawk Therapeutics, Inc.

2.4600+0.06 (+2.5%)

Oct 29, 4:00:00 PM EDT · NasdaqCM · WHWK · USD

Upcoming Earnings

Report date

≈ Nov 5, 2025 (in 6 days)

Key Stats

Market Cap

115.94M

P/E (TTM)

Basic EPS (TTM)

-0.77

Dividend Yield

Recent Filings

10-Q

8/7/25Aug 7, 2025

8-K

8/7/25Aug 7, 2025

8-K

6/13/25Jun 13, 2025

8-K

5/8/25May 8, 2025

10-Q

5/8/25May 8, 2025

About

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

CEO

Dr. David J. Lennon Ph.D.

IPO

2/16/2018

Website

https://ir.whitehawktx.com

Employees

Sector

Healthcare

Industry

Biotechnology